Why Drug Companies Are Rushing to Market Ketamine Medicines

The Quick Take
Spurred on by the Trump administration’s embrace of psychedelic medicine, researchers are experimenting with new — and not so new — forms of the anesthetic.
Ground Level News gathers headlines from public news feeds. This page shows a short summary only; the full article and all rights belong to NYT > Science.



